EXAGEN INC. Repayments of Long-Term Debt
EXAGEN INC. (XGN) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-03-11
- EXAGEN INC. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- EXAGEN INC. repayments of long-term debt for the quarter ending 2024-09-30 was $0.00.
- EXAGEN INC. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- EXAGEN INC. repayments of long-term debt for the quarter ending 2023-09-30 was $0.00.
- EXAGEN INC. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EXAGEN INC. repayments of long-term debt for fiscal 2023 was $10.00M.
- EXAGEN INC. repayments of long-term debt for fiscal 2022 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 10-K · filed 2025-03-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $10.00M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $10.00M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $10.00M 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 10-K · filed 2024-03-18 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |